Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a415aeae6a11cf56

Jump to content

// Workers AI · dad joke modeWhat did CLDN18 say to its friend? "You can clued in on me.

From Wikipedia, the free encyclopedia

CLDN18
Identifiers
AliasesCLDN18, SFTA5, SFTPJ, claudin 18
External IDsOMIM: 609210; MGI: 1929209; GeneCards: CLDN18
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_016369
NM_001002026

NM_001194921
NM_001194922
NM_001194923
NM_019815

RefSeq (protein)

NP_001002026
NP_057453

NP_001181850
NP_001181851
NP_001181852
NP_062789

Location (UCSC)Chr 3: 138 – 138.03 MbChr 9: 99.57 – 99.6 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Claudin-18 is a protein that in humans is encoded by the CLDN18 gene.[5] It belongs to the group of claudins.

CLDN18 belongs to the large claudin family of proteins, which form tight junction strands in epithelial cells .[6] [supplied by OMIM][5]

Clinical significance

[edit]

Isoform 2 (Claudin 18.2) is abundant in gastric tumors.[7]

Zolbetuximab targets Claudin 18.2 to help treat gastric and gastroesophageal junction cancers.[8][9] [10]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000066405 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000032473 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 "Entrez Gene: CLDN18 claudin 18".
  6. ↑ Niimi T, Nagashima K, Ward JM, Minoo P, Zimonjic DB, Popescu NC, et al. (November 2001). "claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing". Molecular and Cellular Biology. 21 (21): 7380–7390. doi:10.1128/MCB.21.21.7380-7390.2001. PMC 99911. PMID 11585919.
  7. ↑ "Antibody Shines in Advanced Gastric Cancer - IMAB362 leads to longer remission, better survival. June 2016". www.medpagetoday.com.
  8. ↑ Astellas Pharma Inc. (2024-03-26). "Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer a". www.prnewswire.com. Cision PR Newswire. Retrieved 2024-09-29.
  9. ↑ Ouladan S, Orouji E (March 2025). "CAR-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy". Journal of Clinical Oncology. 42 (23): 2637–2639. doi:10.1200/JCO.24.02081. PMC 11895826. PMID 39805063.
  10. ↑ Liu J, Yang J, Sun Y, Gong J, Yue J, Pan Y, et al. (September 2025). "CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial". Nature Medicine. 31 (9): 3028–3036. doi:10.1038/s41591-025-03783-8. PMC 12443601. PMID 40670773.
[edit]

Further reading

[edit]